Epstein-Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: Massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage

Immunopharmacology and Immunotoxicology

Volumn 34, Issue 1, 2012, Pages 21-35

  Carter, C J ^a  

^a Polygenic Pathways   (United Kingdom)

Author keywords

Epstein Barr virus; Mimicry; Multiple sclerosis; Synechococcus

Indexed keywords

AUTOANTIGEN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MYELIN; VIRUS PROTEIN; VITAMIN D;

ARTICLE; BACTERIOPHAGE; BRAIN DISEASE; CATTLE; DOG; EPSTEIN BARR VIRUS; GENETIC SUSCEPTIBILITY; HUMAN; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SHEEP; SYNECHOCOCCUS; VANISHING WHITE MATTER DISEASE;

EID: 84055190369     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.3109/08923973.2011.572262     Document Type: Article

References (110)

1. Quintana, F.J., Farez, M.F., Viglietta, V., Iglesias, A.H., Merbl, Y., Izquierdo, G., Lucas, M., Basso, A.S., Khoury, S.J., Lucchinetti, C.F., Cohen, I.R., Weiner, H.L. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci USA 2008, 105, 18889-18894.
2. Wekerle, H., Kojima, K., Lannes-Vieira, J., Lassmann, H., Linington, C. Animal models. Ann Neurol 1994, 36, S47-S53. (Pubitemid 24220843)
3. Ascherio, A., Munger, K.L. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Epstein-Barr virus and multiple sclerosis: epidemiological evidence. Clin Exp Immunol 2010, 160, 120-124.
4. Westall, F.C. Molecular mimicry revisited: gut bacteria and multiple sclerosis. J Clin Microbiol 2006, 44, 2099-2104. (Pubitemid 43902159)
5. Harkiolaki, M., Holmes, S.L., Svendsen, P., Gregersen, J.W., Jensen, L.T., McMahon, R., Friese, M.A., van Boxel, G., Etzensperger, R., Tzartos, J.S., Kranc, K., Sainsbury, S., Harlos, K., Mellins, E.D., Palace, J., Esiri, M.M., van der Merwe, P.A., Jones, E.Y., Fugger, L. T cellmediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 2009, 30, 348-357.
6. Birnbaum, G., Kotilinek, L. Heat shock or stress proteins and their role as autoantigens in multiple sclerosis. Ann N Y Acad Sci 1997, 835, 157-167. (Pubitemid 28046104)
7. Katzourakis, A., Gifford, R.J. Endogenous viral elements in animal genomes. PLoS Genet 2010, 6, e1001191.
8. Geuking, M.B., Weber, J., Dewannieux, M., Gorelik, E., Heidmann, T., Hengartner, H., Zinkernagel, R.M., Hangartner, L. Recombination of retrotransposon and exogenous RNA virus results in nonretroviral cDNA integration. Science 2009, 323, 393-396.
9. Liu, H., Fu, Y., Jiang, D., Li, G., Xie, J., Cheng, J., Peng, Y., Ghabrial, S.A., Yi, X. Widespread horizontal gene transfer from doublestranded RNA viruses to eukaryotic nuclear genomes. J Virol 2010, 84, 11876-11887.
10. Kanduc, D. Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes. Biologics 2010, 4, 245-261.
11. Ricco, R., Kanduc, D. Hepatitis B virus and Homo sapiens proteome-wide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins. Biologics 2010, 4, 75-81.
12. Kanduc, D., Stufano, A., Lucchese, G., Kusalik, A. Massive peptide sharing between viral and human proteomes. Peptides 2008, 29, 1755-1766.
13. Carter, C.J. Alzheimer's disease: a pathogenetic autoimmune disorder caused by herpes simplex in a gene-dependent manner. Int J Alzheimers Dis 2010, 2010, 140539.
14. Trost, B., Lucchese, G., Stufano, A., Bickis, M., Kusalik, A., Kanduc, D. No human protein is exempt from bacterial motifs, not even one. Self Nonself 2011, 1, 1-7.
15. Chatr-aryamontri, A., Ceol, A., Peluso, D., Nardozza, A., Panni, S., Sacco, F., Tinti, M., Smolyar, A., Castagnoli, L., Vidal, M., Cusick, M.E., Cesareni, G. VirusMINT: a viral protein interaction database. Nucleic Acids Res 2009, 37, D669-D673.
16. Navratil, V., De Chassey, B., Combe, C.R., Lotteau, V. When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases. BMC Syst Biol 2011, 5, 13.
17. Altschul, S.F., Madden, T.L., Schäffer, A.A., Zhang, J., Zhang, Z., Miller, W., Lipman, D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997, 25, 3389-3402. (Pubitemid 27359211)
18. Larsen, J.E., Lund, O., Nielsen, M. Improved method for predicting linear B-cell epitopes. Immunome Res 2006, 2, 2.
19. Nielsen, M., Lundegaard, C., Lund, O., Kesmir, C. The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 2005, 57, 33-41. (Pubitemid 40591245)
20. Lill, C.M., McQueen, M.B., Roehr, J.T., Bagade, S., Schjeide, B.M., Zipp, F., Bertram, L. The MSGene Database. Alzheimer Research Forum. http://www.msgene.org/. MsGene 2010.
21. Hindorff, L.A., Junkins, H.A., Hallm P.N., Mehtam J.P., Manolio, T.A. A Catalog of Published Genome-Wide Association Studies. Available at: www.genome.gov/gwastudies.
22. Brocchieri, L., Karlin, S. Protein length in eukaryotic and prokaryotic proteomes. Nucleic Acids Res 2005, 33, 3390-3400. (Pubitemid 41199547)
23. van der Knaap, M.S., Pronk, J.C., Scheper, G.C. Vanishing white matter disease. Lancet Neurol 2006, 5, 413-423.
24. Kurazono, M., Nakamura, K., Yamada, M., Yonemaru, T., Sakoda, T. Pathology of listerial encephalitis in chickens in Japan. Avian Dis 2003, 47, 1496-1502. (Pubitemid 37538180)
25. Andersen, O., Lygner, P.E., Bergström, T., Andersson, M., Vahlne, A. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J Neurol 1993, 240, 417-422. (Pubitemid 23277408)
26. Vartdal, F., Vandvik, B., Norrby, E. Viral and bacterial antibody responses in multiple sclerosis. Ann Neurol 1980, 8, 248-255. (Pubitemid 10018372)
27. Brinar, V.V., Habek, M. Rare infections mimicking MS. Clin Neurol Neurosurg 2010, 112, 625-628.
28. Dean, G., McDougall, E.I., Elian, M. Multiple sclerosis in research workers studying swayback in lambs: an updated report. J Neurol Neurosurg Psychiatr 1985, 48, 859-865. (Pubitemid 15021650)
29. Cook, S.D., Dowling, P.C. A possible association between house pets and multiple sclerosis. Lancet 1977, 1, 980-982. (Pubitemid 8084111)
30. Malosse, D., Perron, H. Correlation analysis between bovine populations, other farm animals, house pets, and multiple sclerosis prevalence. Neuroepidemiology 1993, 12, 15-27. (Pubitemid 23186650)
31. Colson, P., Richet, H., Desnues, C., Balique, F., Moal, V., Grob, J.J., Berbis, P., Lecoq, H., Harlé, J.R., Berland, Y., Raoult, D. Pepper mild mottle virus, a plant virus associated with specific immune responses, fever, abdominal pains, and pruritus in humans. PLoS ONE 2010, 5, e10041.
32. Cantorna, M.T. Vitamin D and multiple sclerosis: an update. Nutr Rev 2008, 66, S135-S138.
33. Shah, K.M., Young, L.S. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin Microbiol Infect 2009, 15, 982-988.
34. Beebe, A.M., Cua, D.J., de Waal Malefyt, R. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 2002, 13, 403-412.
35. Toussirot, E., Roudier, J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 2008, 22, 883-896.
36. Apostolou, F., Gazi, I.F., Lagos, K., Tellis, C.C., Tselepis, A.D., Liberopoulos, E.N., Elisaf, M. Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes. Atherosclerosis 2010, 212, 607-613.
37. Muntoni, S., Muntoni, S. Gene-nutrient interactions in G6PDdeficient subjects-implications for cardiovascular disease susceptibility. J Nutrigenet Nutrigenomics 2008, 1, 49-54. (Pubitemid 350032090)
38. Choi, I.Y., Lee, S.P., Denney, D., Lynch, S. Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T. Mult Scler 2011, 17, 289-296.
39. Back, S.A., Gan, X., Li, Y., Rosenberg, P.A., Volpe, J.J. Maturationdependent vulnerability of oligodendrocytes to oxidative stressinduced death caused by glutathione depletion. J Neurosci 1998, 18, 6241-6253. (Pubitemid 28373231)
40. Paintlia, M.K., Paintlia, A.S., Barbosa, E., Singh, I., Singh, A.K. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res 2004, 78, 347-361. (Pubitemid 39488259)
41. Ram, M., Anaya, J.M., Barzilai, O., Izhaky, D., Porat Katz, B.S., Blank, M., Shoenfeld, Y. The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev 2008, 7, 621-625.
42. Ozakbas, S., Idiman, E., Yulug, B., Pakoz, B., Bahar, H., Gulay, Z. Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leucocyte antigen haplotypes. Tissue Antigens 2006, 68, 235-238. (Pubitemid 44341797)
43. Zivadinov, R., Nasuelli, D., Tommasi, M.A., Serafin, M., Bratina, A., Ukmar, M., Pirko, I., Johnson, A.J., Furlan, C., Pozzi-Mucelli, R.S., Monti-Bragadin, L., Grop, A., Zambon, M., Antonello, R.M., Cazzato, G., Zorzon, M. Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol Res 2006, 28, 262-269. (Pubitemid 43765110)
44. Sutton, I., Lahoria, R., Tan, I., Clouston, P., Barnett, M. CNS demyelination and quadrivalent HPV vaccination. Mult Scler 2009, 15, 116-119.
45. Zwirglmaier, K., Jardillier, L., Ostrowski, M., Mazard, S., Garczarek, L., Vaulot, D., Not, F., Massana, R., Ulloa, O., Scanlan, D.J. Global phylogeography of marine Synechococcus and Prochlorococcus reveals a distinct partitioning of lineages among oceanic biomes. Environ Microbiol 2008, 10, 147-161.
46. Falkner, G., Wagner, F., Falkner, R. On the relation between phosphate uptake and growth of the cyanobacterium Anacystis nidulans. C R Acad Sci III, Sci Vie 1994, 317, 535-541. (Pubitemid 24220256)
47. Green, L.S., Laudenbach, D.E., Grossman, A.R. A region of a cyanobacterial genome required for sulfate transport. Proc Natl Acad Sci USA 1989, 86, 1949-1953.
48. Romero, J.M., Flores, E., Guerrero, M.G. Inhibition of nitrate utilization by amino acids in intact Anacystis nidulans cells. Arch Microbiol 1985, 142, 1-5. (Pubitemid 15054473)
49. Van Baalen, C. The photooxidation of uric acid by Anacystis nidulans. Plant Physiol 1965, 40, 368-371.
50. Irvine, D.G., Schiefer, H.B., Hader, W.J. Geotoxicology of multiple sclerosis: the Henribourg, Saskatchewan, Cluster Focus. I. The water. Sci Total Environ 1989, 84, 45-59.
51. Lee, L.H., Lui, D., Platner, P.J., Hsu, S.F., Chu, T.C., Gaynor, J.J., Vega, Q.C., Lustigman, B.K. Induction of temperate cyanophage AS-1 by heavy metal-copper. BMC Microbiol 2006, 6, 17.
52. Ivanov, A.I., Fomchenkov, V.M., Khasanova, L.A., Kuramshina, Z.M., Sadikov, M.M. [Influence of heavy metal ions on the electrophysical properties of Anacystis nidulans and Escherichia coli cells]. Mikrobiologiia 1992, 61, 455-463.
53. Sherman, D.M., Sherman, L.A. Effect of iron deficiency and iron restoration on ultrastructure of Anacystis nidulans. J Bacteriol 1983, 156, 393-401. (Pubitemid 13022790)
54. Häsänen, E., Kinnunen, E., Alhonen, P. Relationships between the prevalence of multiple sclerosis and some physical and chemical properties of soil. Sci Total Environ 1986, 58, 263-272.
55. Ingalls, T.H. Clustering of multiple sclerosis in Galion, Ohio, 1982- 1985. Am J Forensic Med Pathol 1989, 10, 213-215. (Pubitemid 19215766)
56. Amla, D.V. Drift in ultraviolet sensitivity and expression of mutations during synchronous growth of cyanobacterium Anacystis nidulans. Mutat Res 1983, 107, 229-238. (Pubitemid 13180435)
57. Amla, D.V. Photoreactivation of ultraviolet irradiated blue-green alga: Anacystis nidulans and cyanophage AS-1. Arch Virol 1979, 59, 173-179.
58. Lee, H.L., Cohn, G., Cosowsky, L., McGowan, R., Blamire, J. DNA metabolism during infection of Anacystis nidulans by cyanophage AS-1. VII. UV-induced alterations of the AS-1/A. nidulans lytic cycle. Microbios 1985, 43, 277-295. (Pubitemid 16162251)
59. Beretich, B.D., Beretich, T.M. Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis. Mult Scler 2009, 15, 891-898.
60. Lucas, R.M., Ponsonby, A.L., Dear, K., Valery, P.C., Pender, M.P., Taylor, B.V., Kilpatrick, T.J., Dwyer, T., Coulthard, A., Chapman, C., van der Mei, I., Williams, D., McMichael, A.J. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011, 76, 540-548.
61. Ramagopalan, S.V., Heger, A., Berlanga, A.J., Maugeri, N.J., Lincoln, M.R., Burrell, A., Handunnetthi, L., Handel, A.E., Disanto, G., Orton, S.M., Watson, C.T., Morahan, J.M., Giovannoni, G., Ponting, C.P., Ebers, G.C., Knight, J.C. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010, 20, 1352-1360.
62. Courbebaisse, M., Souberbielle, J.C., Prié, D., Thervet, E. [Non phosphocalcic actions of vitamin D]. Med Sci (Paris) 2010, 26, 417-421.
63. Bains, W. Exposure of the eyes to near-horizon sunshine may be a trigger for multiple sclerosis. Med Hypotheses 2010, 74, 428-432.
64. Meier, D.S., Balashov, K.E., Healy, B., Weiner, H.L., Guttmann, C.R. Seasonal prevalence of MS disease activity. Neurology 2010, 75, 799-806.
65. Salvi, F., Bartolomei, I., Smolensky, M.H., Lorusso, A., Barbarossa, E., Malagoni, A.M., Zamboni, P., Manfredini, R. A seasonal periodicity in relapses of multiple sclerosis? A single-center, population-based, preliminary study conducted in Bologna, Italy. BMC Neurol 2010, 10, 105.
66. Klupka-Saric, I., Galic, M. Epidemiology of multiple sclerosis inwestern Herzegovina and Herzegovina-Neretva Canton, Bosnia and Herzegovina. Coll Antropol 2010, 34(Suppl 1), 189-193.
67. Abad, P., Pérez, M., Castro, E., Alarcón, T., Santibáñez, R., Díaz, F. [Prevalence of multiple sclerosis in Ecuador]. Neurologia 2010, 25, 309-313.
68. Fromont, A., Binquet, C., Sauleau, E.A., Fournel, I., Bellisario, A., Adnet, J., Weill, A., Vukusic, S., Confavreux, C., Debouverie, M., Clerc, L., Bonithon-Kopp, C., Moreau, T. Geographic variations of multiple sclerosis in France. Brain 2010, 133, 1889-1899.
69. Materljan, E., Materljan, M., Materljan, B., Vlacic, H., Baricev- Novakovic, Z., Sepcic, J. Multiple sclerosis and cancers in Croatia-a possible protective role of the "Mediterranean diet". Coll Antropol 2009, 33, 539-545.
70. Larsen, J.P., Riise, T., Nyland, H., Kvåle, G., Aarli, J.A. Clustering of multiple sclerosis in the county of Hordaland, Western Norway. Acta Neurol Scand 1985, 71, 390-395. (Pubitemid 15001006)
71. Trost, B., Kusalik, A., Lucchese, G., Kanduc, D. Bacterial peptides are intensively present throughout the human proteome. Self Nonself 2010, 1, 71-74.
72. Wang, H., Munger, K.L., Reindl, M., O'Reilly, E.J., Levin, L.I., Berger, T., Ascherio, A. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults. Neurology 2008, 71, 1142-1146.
73. Lünemann, J.D., Jelcic, I., Roberts, S., Lutterotti, A., Tackenberg, B., Martin, R., Münz, C. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 2008, 205, 1763-1773.
74. Carter, C.J. Interactions between the products of the herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades. Neurochem Int 2008, 52, 920-934.
75. Carter, C.J. Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii. Schizophr Bull 2009, 35, 1163-1182.
76. Mullen, M.M., Haan, K.M., Longnecker, R., Jardetzky, T.S. Structure of the Epstein-Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol Cell 2002, 9, 375-385. (Pubitemid 34195562)
77. Yenamandra, S.P., Hellman, U., Kempkes, B., Darekar, S.D., Petermann, S., Sculley, T., Klein, G., Kashuba, E. Epstein- Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. Cell Mol Life Sci 2010, 67, 4249-4256.
78. Frémeaux-Bacchi, V., Bernard, I., Maillet, F., Mani, J.C., Fontaine, M., Bonnefoy, J.Y., Kazatchkine, M.D., Fischer, E. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23. Eur J Immunol 1996, 26, 1497-1503. (Pubitemid 26229994)
79. Peters, A.L., Stunz, L.L., Meyerholz, D.K., Mohan, C., Bishop, G.A. Latent membrane protein 1, the EBV-encoded oncogenic mimic of CD40, accelerates autoimmunity in B6.Sle1 mice. J Immunol 2010, 185, 4053-4062.
80. Rothenberger, S., Burns, K., Rousseaux, M., Tschopp, J., Bron, C. Ubiquitination of the Epstein-Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site. Oncogene 2003, 22, 5614-5618. (Pubitemid 37102697)
81. Wang, Z., Luo, F., Li, L., Yang, L., Hu, D., Ma, X., Lu, Z., Sun, L., Cao, Y. STAT3 activation induced by Epstein-Barr virus latent membrane protein1 causes vascular endothelial growth factor expression and cellular invasiveness via JAK3 And ERK signaling. Eur J Cancer 2010, 46, 2996-3006.
82. Geiger, T.R., Martin, J.M. The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells. J Virol 2006, 80, 11638-11650. (Pubitemid 44788878)
83. Ning, S., Huye, L.E., Pagano, J.S. Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit. J Virol 2005, 79, 11671-11676. (Pubitemid 41279285)
84. Kvansakul, M., Wei, A.H., Fletcher, J.I., Willis, S.N., Chen, L., Roberts, A.W., Huang, D.C., Colman, P.M. Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1. PLoS Pathog 2010, 6, e1001236.
85. Bristol, J.A., Robinson, A.R., Barlow, E.A., Kenney, S.C. The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteins. J Virol 2010, 84, 12362-12374.
86. Fukuda, M., Kurosaki, H., Sairenji, T. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation. J Med Virol 2006, 78, 1456-1464. (Pubitemid 44533876)
87. Peel, A.L. PKR activation in neurodegenerative disease. J Neuropathol Exp Neurol 2004, 63, 97-105. (Pubitemid 38174774)
88. Wozniak, M.A., Shipley, S.J., Dobson, C.B., Parker, S.P., Scott, F.T., Leedham-Green, M., Breuer, J., Itzhaki, R.F. Does apolipoprotein E determine outcome of infection by varicella zoster virus and by Epstein-Barr virus? Eur J Hum Genet 2007, 15, 672-678. (Pubitemid 46825057)
89. Hughes, L.E., Smith, P.A., Bonell, S., Natt, R.S., Wilson, C., Rashid, T., Amor, S., Thompson, E.J., Croker, J., Ebringer, A. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J Neuroimmunol 2003, 144, 105-115. (Pubitemid 37329935)
90. Carter, C.J. Alzheimer's disease plaques and tangles: Cemeteries of a Pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction. Neurochem Int 2011, 58, 301-320.
91. Rivers, T.M., Sprunt, D.H., Berry, G.P. OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS. J Exp Med 1933, 58, 39-53.
92. Wang, J.H., Pappas, D., De Jager, P.L., Pelletier, D., de Bakker, P.I., Kappos, L., Polman, C.H., Chibnik, L.B., Hafler, D.A., Matthews, P.M., Hauser, S.L., Baranzini, S.E., Oksenberg, J.R.; Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene). Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data. Genome Med 2011, 3, 3.
93. Lettre, G., Rioux, J.D. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008, 17, R116-R121.
94. Jonsson, R., Nakken, B., Halse, A.K., Skarstein, K., Brokstad, K., Haga, H.J. [Heredity and immunology in Sjogren's syndrome]. Tidsskr Nor Laegeforen 2000, 120, 811-814.
95. Phillips, D., Prentice, L., Upadhyaya, M., Lunt, P., Chamberlain, S., Roberts, D.F., McLachlan, S., Smith, B.R. Autosomal dominant inheritance of autoantibodies to thyroid peroxidase and thyroglobulin-studies in families not selected for autoimmune thyroid disease. J Clin Endocrinol Metab 1991, 72, 973-975. (Pubitemid 21921793)
96. Janeway, C.A., Travers, P., Walport, M., Schlonchik, M.J. The Immune System in Health and Disease. New York: Garland Science, 2011.
97. Bartsch, S., Montag, D., Schachner, M., Bartsch, U. Increased number of unmyelinated axons in optic nerves of adult mice deficient in the myelin-associated glycoprotein (MAG). Brain Res 1997, 762, 231-234. (Pubitemid 27315956)
98. Martini, R., Mohajeri, M.H., Kasper, S., Giese, K.P., Schachner, M. Mice doubly deficient in the genes for P0 and myelin basic protein show that both proteins contribute to the formation of the major dense line in peripheral nerve myelin. J Neurosci 1995, 15, 4488-4495.
99. Aboul-Enein, F., Rauschka, H., Kornek, B., Stadelmann, C., Stefferl, A., Brück, W., Lucchinetti, C., Schmidbauer, M., Jellinger, K., Lassmann, H. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 2003, 62, 25-33. (Pubitemid 36068890)
100. Pardridge, W.M. Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses. Bioconjug Chem 2008, 19, 1327-1338. (Pubitemid 352032329)
101. Mallery, D.L., McEwan, W.A., Bidgood, S.R., Towers, G.J., Johnson, C.M., James, L.C. Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21). Proc Natl Acad Sci USA 2010, 107, 19985-19990.
102. Ulzheimer, J.C., Meuth, S.G., Bittner, S., Kleinschnitz, C., Kieseier, B.C., Wiendl, H. Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of immunomodulatory treatment strategies. BioDrugs 2010, 24, 249-274.
103. Hosokawa, S., Oyamaguchi, A., Yoshida, O. Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis. ASAIO Trans 1989, 35, 576-577. (Pubitemid 20118308)
104. Cortese, I., Chaudhry, V., So, Y.T., Cantor, F., Cornblath, D.R., Rae-Grant, A. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2011, 76, 294-300.
105. Moldenhauer, A., Haas, J., Wäscher, C., Derfuss, T., Hoffmann, K.T., Kiesewetter, H., Salama, A. Immunoadsorption patients with multiple sclerosis: an open-label pilot study. Eur J Clin Invest 2005, 35, 523-530. (Pubitemid 41153207)
106. Nomura, K. [Therapeutic apheresis in multiple sclerosis]. Nippon Rinsho 2003, 61, 1388-1395.
107. De Andrés, C., Anaya, F., Giménez-Roldán, S. [Plasma immunoadsorption treatment of malignant multiple sclerosis with severe and prolonged relapses]. Rev Neurol 2000, 30, 601-605.
108. Palm, M., Behm, E., Schmitt, E., Buddenhagen, F., Hitzschke, B., Kracht, M., Kundt, G., Meyer-Rienecker, H., Klinkmann, H. Immunoadsorption and plasma exchange in multiple sclerosis: complement and plasma protein behaviour. Biomater Artif Cells Immobilization Biotechnol 1991, 19, 283-296.
109. Schneidewind, J.M., Winkler, R., Ramlow, W., Tiess, M., Hertel, U., Sehland, D. Immunoadsorption-a new therapeutic possibility for multiple sclerosis? Transfus Sci 1998, 19, 59-63.
110. Schweigreiter, R. The natural history of the myelin-derived nerve growth inhibitor Nogo-A. Neuron Glia Biol 2008, 4, 83-89.